Podcast appearances and mentions of David L Nathan

In this episode, our guest is Dr. David L. Nathan, M.D., psychiatrist, founder of Doctors for Drug Policy Reform (D4DPR), and creator of the universal cannabis symbol. We talk about his motivation behind founding a non-profit and the challenges that came with it. We also explore what it's like working with politicians to make physician voices heard and to create evidence-based policies. In 2019, Dr. Nathan testified in front of the Congressional Judiciary Committee regarding cannabis regulation and legalization. He professes his love for graphic designing and labeling which, with the help of his son, Eli, led to the creation of the International Intoxicating Cannabis Products Symbol (IICPS), adopted by four states now. This episode ought to be of interest to anyone interested in advocacy work in healthcare and understanding a doctor's perspective on drug legalization and regulation in the U.S. Follow us on Twitter @doctorscreate to meet more creative doctors! This episode was hosted and edited by David Park. Music for this episode is credited to Nightfloat. Timestamps (00:57) What's D4DPR? (02:08) What does D4DPR do? (05:17) Biden pardons Marijuana users (07:44) Starting a non-profit (14:30) Testifying in front of Congress (16:00) Increase in ER visits by children in newly legalized states? (21:40) Evidence-based public health policy (26:13) Risks of underage use of cannabis (32:40) Designing the universal cannabis symbol (37:37) Destigmatizing cannabis use (40:50) Hit'em where they ain't

The cannabis industry won at the ballot box in the recent election, with four states passing laws to make cannabis legal for adults and two approving cannabis for medical purposes. These results moved the National Cannabis Industry Association (NCIA) closer to its goal of building a robust cannabis industry while supporting state laws and advocating for federal policy reforms.    On November 3, 2020, voters in five states made a definitive statement about cannabis use. Arizona, Montana, New Jersey, and South Dakota approved adult use of cannabis. South Dakota also approved a medical initiative, along with Mississippi, which approved comprehensive cannabis medical options.   The National Cannabis Industry Association (NCIA) has been working toward outcomes such as these since 2010. With 2,000 members nationwide, the organization is supporting the industry as cannabis becomes a thriving business and a real economic force. In recent years, NCIA has been a vocal advocate for social equity, working to promote expungement of criminal records of many people—largely from minority communities—who were unfairly incarcerated as part of the ill-conceived War on Drugs. The results of the initiatives in these five states illustrate how far the industry has come. The people have spoken, and their voice was definitive. “The margins were higher than we expected,” says Morgan Fox, spokesperson for NCIA. “In Arizona, there was a 60% margin, while the margin in New Jersey was 66%, 10 points higher than it was in California when it passed an adult use initiative in 2016. These results are not just political victories; they will likely have widespread ramifications. Importantly, it will be much more difficult for law enforcement to use cannabis as a weapon against minority populations. Instead, we will likely see more economic opportunities in the industry and fewer arrests overall.” Although there were differences among the measures passed, those that supported legalization all set 21 as the legal age for use. In New Jersey, the law requires that the state set a regulatory structure, along with limits for possession and homegrown cannabis plants. Arizona established the number of plants allowed at six, while South Dakota limited cultivation to three. The law in Arizona also stated that the Department of Health Services must promote business ownership and industry participation among people from communities who have been harmed by former cannabis policies. Furthermore, a portion of cannabis tax revenue will be set aside for the newly created Justice Reinvestment Fund.     To date, almost 34% of Americans live in states with laws establishing cannabis as legal and regulated for adults. Four of the five states that recently passed laws legalizing cannabis have been responsible for roughly 60,000 cannabis arrests each year, mostly for simple possession. On the economic side, researchers estimate that the combined value of the cannabis markets in these five states will climb to more than $3.1 billion by 2025. In states where cannabis is now legal, Congressional representation will increase by 29 representatives and eight senators. In sum, cannabis is now legal for adults in 15 states, as well as the District of Columbia and the territories of CNMI and Guam. What’s more, 36 states and several territories have comprehensive medical cannabis laws. Cannabis is now legal in some form in 47 states in the United States. Guests:  David L. Nathan, MD, DFAPA President, Board of Directors Doctors for Cannabis Regulation Abby Stoddard, PharmD, MBA  The Client Centered Network www.clientcn.com  See omnystudio.com/listener for privacy information.

LIVE from Element by Westin in Bloomington, MN, it is Gratitude:UnFiltered....... David L. Nathan, MD, DFAPA is a Princeton, New Jersey based psychiatrist, writer, speaker, educator, and consultant. He is the founder and board president of Doctors for Cannabis Regulation and a founding steering committee member of New Jersey United for Marijuana Reform. Recently, he […]

LIVE from Element by Westin in Bloomington, MN, it is Gratitude:UnFiltered……. David L. Nathan, MD, DFAPA is a Princeton, New Jersey based psychiatrist, writer, speaker, educator, and consultant. He is the founder and board president of Doctors for Cannabis Regulation and a founding steering committee member of New Jersey United for Marijuana Reform. Recently, he was named as one of five leaders of the newly formed coalition to support New Jersey’s 2020 cannabis legalization ballot initiative. Dr. Nathan was the first physician in New Jersey history to testify in favor of cannabis legalization before the state legislature, and he has provided a total of 15 testimonies in eight US states. In 2019, Dr. Nathan was one of two physicians to testify at the first-ever US House Judiciary Committee hearing on cannabis legalization. Dr. Nathan is a Distinguished Fellow of the American Psychiatric Association and Clinical Associate Professor of Psychiatry at Rutgers Robert Wood Johnson Medical School. He graduated magna cum laude from Princeton University, received his MD from the University of Pennsylvania School of Medicine, and completed his psychiatry residency at McLean Hospital of Harvard Medical School. While a medical student at Penn Med, Dr. Nathan created, designed, illustrated, and supervised the completion of medical education software packages for anatomy, histology, and embryology. These early GUI programs were used in medical schools around the world. Dr. Nathan serves as Director of Continuing Medical Education for Penn Medicine Princeton Health and Director of Professional Education at Princeton House Behavioral Health. On the topic of cannabis policy, Dr. Nathan does not necessarily represent the views of these organizations. Dr. Nathan is a clinical associate professor at Rutgers RWJ Medical School and a community fellow at Mathey College of Princeton University. Recently, he was appointed to the Editorial Boards of the American Journal of Endocannabinoid Medicine and Cannabis Science and Technology. Dr. Nathan has written and spoken extensively on cannabis policy, with audiences including lawmakers, businesspeople, state medical societies, hospital medical staff, allied health professionals, and the lay public. Among his dozens of published articles, he coauthored a landmark opinion piece on cannabis regulation with former Surgeon General Joycelyn Elders for the American Journal of Public Health. Dr. Nathan has appeared in nationally syndicated broadcast, online and print media publications, with more prominent outlets including CNN, The New York Times, Wall Street Journal, Washington Post, US News & World Report, VICE News, San Francisco Chronicle, Politico, The Week (UK), and SinoVision News. He has also appeared in many state/province and local media outlets around the United States and Canada. Dr. Nathan serves as a cannabis consultant for government and industry. He has assisted several cannabis companies with license applications in three states and has served as the Chief Medical Advisor for a multistate medical cannabis company. In his spare time, Dr. Nathan has published articles on a variety of historical topics, including early written language, numismatics, animation, and the dawn of American football.

Hello my fellow Hemp nuts! Are you ready for the cannabis bonanza?! Thank you to our Patreon supporters!https://www.patreon.com/newhemptimesGreer Barnes (HBO crashing, Chapelle Show) , the Unapologetic Farmer Randy Cameroon, Jr, Jan Roberts, LCSW, and Jahan Marcu, Ph.D dig into recent marijuana science and news after a brief discussion of their week.Show Segments:The Check-In with Jan Roberts, LCSWOur word of the day is HarshiniResearch Focus/High Science: THC Analysis in the Dead- interesting implications for policy because of this new dataCannaBusting - Finding or Fiction We will test your knowledge of recent cannabis news and scienceApril 20th? What does it mean to each us?Listener Call in, Q and AMind MunchiesWORD OF THE DAY:Harshini the exciter of sexual desire, the rejoicer, delight-giver, causer of elationHIGH SCIENCE/RESEARCH FOCUS:Today’s High science research focus, is bigger than the discovery gravitational waves!New evidence may invalidate a lot of THC testing that is done after people die from accidents or natural causes. Research tries to tie MJ to deaths by looking at levels in the body after people die. Researchers/toxicologists have found what is described as “Oh my god” levels of THC in post mortem analysis.Post-Mortem THC levels do not shed light on intoxication LevelsResearchers have found that the death greatly affects THC levels in the blood. Potentially discounting all roadside and death related research into cannabis.If you take a blood sample from a living person, and it is low or within legal limit, but if the day that day, the levels shoot up to “oh my god” levels, due to the body breaking down and releasing it.Coroners/toxicologists being asked to determine whether marijuana played a role in death state that “we couldn't really answer that question, it is not scientifically possible. because what happens is that if take you the sample after death the results produce artificially high, “sky high”, levels of THC that make you think “oh my god” by in facts its just an artifact from the body breaking down.“We cant rely on post-mortem THC concentrations when it come to the impairment that somebody was at or the level they had in their the system when they were alive.”The fresher the body, the lower the blood levels of THC.https://www.csindy.com/coloradosprings/study-finds-postmortem-thc-tests-dont-shed-light-on-intoxication-levels-before-death/Content?oid=19419481CANNABUSTING: Finding or Fiction?Former Surgeon General Joycelyn Elders coauthored an op-ed on modern-day "Reefer Madnesshttps://www.psychiatrictimes.com/cultural-psychiatry/21st-century-reefer-madness• David L. Nathan, MD• Joycelyn Elders, MD• Bryon Adinoff, MD“we acknowledge one key point of agreement with Berenson: Research does show that cannabis can trigger or worsen psychosis in predisposed individuals. Indeed, we have spent years educating the public about this risk.”“We appeal to government officials, the public, and our fellow physicians to support the sensible regulation of adult cannabis use as a more humane and cost-effective alternative to prohibition. Our nation must embrace science, reject misguided moralism around cannabis use, and recognize that books like Berenson’s are exactly what he inadvertently entitled his own: Reefer Madness.”Washington State Gov. Jay Inslee (D), a presidential candidate, implied that he consumed high-quality marijuana in the 1970shttps://mobile.twitter.com/PodSaveAmerica/status/1117955769419198464Rep. Diana DeGette (D-CO) tweeted a photo of herself meeting with marijuana business owners who "are worried that the feds could step-in at any moment and shut them down. Marijuana is now a multi-billion-dollar industry in our state. We shouldn’t have to worry about suddenly losing a key part of our economy.”From Twitter(NAT) Cannabis vaping device maker seeks to inhale $400 million in funding | San Francisco Business Times / The vaping company that used to operate Juul is seeking to inhale 400 million in funding for a cannabis vape https://www.bizjournals.com/sanfrancisco/news/2019/04/16/pax-labs-seeks-to-inhale-400-million-in-funding.htmlPax labs is hitching its star to the cannabis markets. PAX labs is seeking 400million in fund raises after Juul Labs spun out of it operation.(INT) Canopy Growth Buys Spanish Cannabis Company Cafina in All-Cash Deal | The Streethttps://www.thestreet.com/investing/cannabis/canopy-growth-acquires-spanish-cannabis-company-cafina-in-all-cash-deal-14928508Adds to its European facilities in Denmark and GermanyCarl’s Jr Announces Trial Run of CBD burger (5mg in the sauce)https://www.cnn.com/2019/04/17/business/carls-jr-cbd-burger/index.htmlThe company announced for one day only, at one location in Colorado, on 4/20, the will sell a CBD burger, under the name “Rocky Mountain High” Burger.SCIENCE FINDINGS OR FICTIONSA recent study conducted by a federal agency, on Police Officer Exposure to cannabis smoke at stadium events, found that over half of officers tested positive for THC afterand they concluded with the recommendation that those officers who are bothered by marijuana smoke and its effects should be assigned to other locations (where exposure .)Evaluation of Police Officer Exposure to Secondhand cannabis smoke at Open-air Stadium events.Researchers involved Police officers who worked in areas around and within the University’s football stadium (50K+ capacity). Officers were assigned to patrol various areas in on foot, bicycle, and various small vehicles. Before, after, and during concert events.19 of 29 (66%) had detectable levels of THC in their blood.Symptoms reported were red eyes, dry mouth, headache, and coughing, were reported by over 20% of officers.However, subjective reporting of a contact high was low.One of the Recommendations:Recommendations: Assign police officers who report being bothered by secondhand marijuana smoke should be assigned to other locations, where exposure would be low or non-existent.A study of police officers' exposure to secondhand marijuana smoke at open-air stadium events found "measurable amounts of THC in personal and area air samples" and that "small amounts of THC-COOH, a chemical marker of THC exposure, were detected in urine samples, but not in blood samples," but that "the amount found in the urine would not be considered positive in a routine drug screening test."https://stacks.cdc.gov/view/cdc/77396Preventative Medicine Reports Indoor Cannabis Smoke and Children’s HealthA recent study found that the air quality of cannabis smoking households is linked to a greater number of adverse health outcomes (but not because of the drugs effect.)A study found that "odds of reporting a greater number of adverse health outcomes were 1.83 times higher for children of families with indoor cannabis smoking vs families without cannabis smoking, after controlling for exposure to cigarette smoke and other covariates" but that "our results do not indicate a statistically significant association."Air particle monitors were placed in 298 homes with at least one child under 14.15% smoked cannabis indoors, 48% of those said they smoked cigerettes inside.Health outcomes : 31% said none, 44.8% said 1, and 24.1% reported 2 or more.Types of outcomes: ED visits, ear infection, bronchitis, asthma, skin conditionsDue to higher particulate matter in the air, lower air quality.https://www.sciencedirect.com/science/article/pii/S2211335519300385?via%3DihubScience/Human: The use of synthetic cannabinoids is associated with more mental health problems compared to natural cannabisAccording to an online survey with 367 users of synthetic cannabinoids and natural cannabis, those who used synthetic cannabinoids scored higher on drug abuse, sleep problems, depression, anxiety and other mental health problems.Department of Drug Monitoring, Utrecht, The Netherlands.Mensen VT, et al. Psychopharmacology (Berl). 2019 Apr 9. [in press]Science/Animal: Interaction between ketamine and the endocannabinoid systemA study with mice suggests that antidepressant effects of ketamine are mediated by cannabinoid receptors.Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.Khakpai F, et al. Biomed Pharmacother. 2019 Apr;112:108717.Researchers publish article detailing strategies for producing GIANT hempseed and cannabis crops.Concluding the urgent need to develop public gene bank collections of cannabis.Criticizes cannabis producers for their shortsightedness for eliminating cannabis germ plasm, because cannabis biomass has a lot of genetic diversity. No R&D on cannabis varieties.Genetic Resources and Crop Evaluationhttps://link.springer.com/article/10.1007%2Fs10722-017-0597-y See acast.com/privacy for privacy and opt-out information.